These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28627469)

  • 21. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Release of poorly soluble drugs from HPMC tablets studied by FTIR imaging and flow-through dissolution tests.
    van der Weerd J; Kazarian SG
    J Pharm Sci; 2005 Sep; 94(9):2096-109. PubMed ID: 16052556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studying Drug Release through Polymeric Controlled Release Formulations in United States Pharmacopoeia 2 Apparatus Using Multiphysics Simulation and Experiments.
    Ranjan A; Jha PK
    Mol Pharm; 2021 Jul; 18(7):2600-2611. PubMed ID: 34056905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models.
    Uebbing L; Klumpp L; Webster GK; Löbenberg R
    Drug Des Devel Ther; 2017; 11():1163-1174. PubMed ID: 28442890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined study of biphasic and zero-order release formulations with dissolution tests and ATR-FTIR spectroscopic imaging.
    Wray P; Li J; Li LQ; Kazarian SG
    J Pharm Sci; 2014 Jul; 103(7):1995-2004. PubMed ID: 24801351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
    Bravo SA; Lamas MC; Salamón CJ
    J Pharm Pharm Sci; 2002; 5(3):213-9. PubMed ID: 12553888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of individual gastric emptying of pellets in the prediction of diclofenac in vivo dissolution.
    Klein S; Garbacz G; Pišlar M; Locatelli I; Liu C; Weitschies W; Siegmund W; Mrhar A; Bogataj M
    J Control Release; 2013 Mar; 166(3):286-93. PubMed ID: 23306025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxyethyl Pachyman as a novel excipient for sustained-release matrix tablets.
    Zhou X; Wang P; Wang J; Liu Z; Hong X; Xiao Y; Liu P; Hu X
    Carbohydr Polym; 2016 Dec; 154():1-7. PubMed ID: 27577889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of dissolution conditions on the drug ADME phenomena.
    Cascone S; De Santis F; Lamberti G; Titomanlio G
    Eur J Pharm Biopharm; 2011 Oct; 79(2):382-91. PubMed ID: 21515367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates.
    Shah S; Khan GM; Jan SU; Shah K; Hussain A; Khan H; Khan H; Khan H; Khan KA
    Pak J Pharm Sci; 2012 Jan; 25(1):161-8. PubMed ID: 22186325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral controlled release formulation of diclofenac sodium by microencapsulation with ethyl cellulose.
    Sajeev C; Vinay G; Archna R; Saha RN
    J Microencapsul; 2002; 19(6):753-60. PubMed ID: 12569023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns.
    Shah SU; Shah KU; Rehman A; Khan GM
    Pak J Pharm Sci; 2011 Apr; 24(2):183-92. PubMed ID: 21454168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Drug Release Testing to Evaluate the Retention of Abuse-Deterrent Properties of Polyethylene Oxide Matrix Tablets.
    Meruva S; Rezaei L; Thool P; Donovan MD
    AAPS PharmSciTech; 2020 Oct; 21(7):270. PubMed ID: 33025237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality surveillance of immediate release aceclofenac tablets (100 mg) available in local market.
    Bushra R; Shoaib MH; Ali H; Shafiq Y; Zafar F; Alam S; Aslam N
    Pak J Pharm Sci; 2017 Nov; 30(6):2193-2201. PubMed ID: 29175789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation and in vitro evaluation of directly compressed controlled release tablets designed from the Co-precipitates.
    Khan KA; Khan GM; Jan SU; Rehman A; Mehsud S
    Pak J Pharm Sci; 2018 Mar; 31(2):455-461. PubMed ID: 29618434
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Medina-López R; Guillén-Moedano S; Hurtado M
    ADMET DMPK; 2020; 8(4):411-423. PubMed ID: 35300193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study on the in vitro performance of blister molded and conventional lornoxicam immediate release liquitablets: accelerated stability study and anti-inflammatory and ulcerogenic effects.
    El-Setouhy DA; Gamiel AA; Badawi AA; Osman AS; Labib DA
    Pharm Dev Technol; 2017 Mar; 22(2):256-265. PubMed ID: 27494155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An alternative method to the evaluation of similarity factor in dissolution testing.
    Costa P
    Int J Pharm; 2001 Jun; 220(1-2):77-83. PubMed ID: 11376969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Intestine Model Apparatus for Drug Dissolution Capable of Simulating the Peristaltic Action.
    Hribar M; Trontelj J; Klančar U; Markun B; Čeligoj Dujc T; Legen I
    AAPS PharmSciTech; 2017 Jul; 18(5):1646-1656. PubMed ID: 27663704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.